Keywords: merck, sales, up, amid, fears, future, pharmaceutical
Merck's Sales Up 19% Amid Fears For The Future
Article | 17 October 1997
US pharmaceutical giant Merck & Co has announced that third-quarter netincome rose 19% to $1.2 billion, or $0.99 per share, on revenues of $5.9 billion, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
